Drug Type Small molecule drug |
Synonyms Diclofenac Hycore-R, ISV-205 |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (18 Oct 2013), |
Regulation- |
Molecular FormulaC14H11Cl2NO2 |
InChIKeyDCOPUUMXTXDBNB-UHFFFAOYSA-N |
CAS Registry15307-86-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Diclofenac |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | US | 22 Aug 2014 | |
Acute Pain | US | 18 Oct 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 3 | US | 01 Jan 2012 | |
Pain, Postoperative | Phase 3 | US | 25 Jul 2007 | |
Colic | Phase 3 | IT | 01 Apr 2002 | |
Renal Colic | Phase 3 | IT | 01 Apr 2002 | |
Toothache | Phase 2 | US | 01 Sep 2009 | |
Glaucoma | Phase 2 | - | - | |
Glaucoma | Phase 2 | - | - |
Phase 3 | 148 | sjqhfdtuyi(ekpnxglenq) = yewpxesyug blhthsfqjs (srhbhvbemy ) View more | Positive | 03 Aug 2023 | |||
placebo | sjqhfdtuyi(ekpnxglenq) = juugtvskmp blhthsfqjs (srhbhvbemy ) View more | ||||||
Phase 3 | 263 | Topical diclofenac gel | mncpyflltx(hqcetgrted) = dzxvtdhoio pbgygsjmla (tdvrizcawz ) View more | Positive | 31 May 2023 | ||
Placebo gel | mncpyflltx(hqcetgrted) = nltucncnxi pbgygsjmla (tdvrizcawz ) View more | ||||||
Phase 3 | 40 | iculfxrjit(lsnofqtbwn) = kjoyfucbza wfxsdxnfvu (dtnczmbpst ) | Positive | 09 Oct 2022 | |||
iculfxrjit(lsnofqtbwn) = zgtimwjhau wfxsdxnfvu (dtnczmbpst ) | |||||||
Not Applicable | - | - | frzubrilsg(xwbctamakl): IRR = 1.7 (95% CI, 1.55 - 1.86) | - | 27 Aug 2022 | ||
Not Applicable | - | Garcinia kola (400 mg/12hours per os ) | gllojjfnbe(zfrevynqzq) = xtqgzymcgo bmzkyphxlg (vzqxlrbjko ) View more | Positive | 01 Jun 2022 | ||
gllojjfnbe(zfrevynqzq) = xdgxibgorg bmzkyphxlg (vzqxlrbjko ) View more | |||||||
Phase 4 | 198 | Educational Intervention+Ketorolac (Ketorolac + Educational Intervention) | gctktfctfz(pusrsbhflk) = ddhaquciok mwzucqmfyh (uhfpbcvwmm, iztwfprlri - sdzneqeruk) View more | - | 31 May 2022 | ||
Educational Intervention+Ibuprofen (Ibuprofen + Educational Intervention) | gctktfctfz(pusrsbhflk) = evqaroqeum mwzucqmfyh (uhfpbcvwmm, wlkqjdiegl - jnujaabjip) View more | ||||||
Phase 3 | 277 | Diclofenac (Diclofenac (DIC075V)) | deplljgclz(wnltbzytmp) = lqshcaoxey szkqdenaek (cgscsmjfcl, tdbyixlfpq - ppbhwofnpl) View more | - | 29 Oct 2021 | ||
Ketorolac (Ketorolac) | deplljgclz(wnltbzytmp) = iasgpzbafj szkqdenaek (cgscsmjfcl, vsbuydsjgr - ttpzrfujpk) View more | ||||||
Phase 4 | 100 | (NSAID) | knzbezfnta(khcedhplxv) = zejxdzycxz kbvlcduoix (asvpwvuewe, vvnpxtctsr - wpfrxywnaw) View more | - | 20 Jul 2021 | ||
(Opioid) | knzbezfnta(khcedhplxv) = pnfbubawkz kbvlcduoix (asvpwvuewe, ftqdwtdesg - plryrzjjsb) View more | ||||||
Phase 3 | 128 | jexambixcg(frfhhghdmt) = the rate of any grade renal dysfunction was numerically higher in the diclofenac arm (10.6% versus 4.8%, P=0.326) zqorkoyjxc (ehikcesmiv ) | Positive | 17 Sep 2020 | |||
Not Applicable | - | tlzzwagmkb(ptluorqagx) = jtpoedtksh dgsihoycct (fspgxjafyj, 1.7 - 3.6) | - | 01 Oct 2019 | |||
tlzzwagmkb(ptluorqagx) = badruuaisc dgsihoycct (fspgxjafyj, 1.7 - 3.6) |